Product features

  • ¬¨‚ĆOtrivine is a highly effective decongestant which acts gently within minutes to relieve nasal congestion associated with sinusitis for up to ten hours.

Product description

Otrivine® Adult Measured Dose Sinusitis Spray delivers a measured fine mist of medication with each application. Otrivine is a highly effective decongestant which acts gently within minutes to relieve nasal congestion associated with sinusitis for up to ten hours.

  • Specifications

    Manufacturer GlaxoSmithKline Consumer Healthcare (Ireland) Limited Pack_Unit_Type Box Item_Size 10 Item_Size_Unit ml e

  • Suitable for

    12+

  • Warnings and cautions

    Keep all medicines out of the reach and sight of children. If you are pregnant or taking other medicines or are under a doctor's care consult your doctor before using Otrivine. Contains benzalkonium chloride, see leaflet for further information. Do not use continuously for more than seven consecutive days. If symptoms persist consult your doctor. Warning: Do not exceed the stated dose. Not suitable for children and infants under 12 years. For reasons of hygiene do not use this bottle more than 28 days after first opening it. Each Otrivine pack should be used by one person only to prevent any cross infection. Do not use after the expiry date given.

  • How to use

    Directions: For nasal use. Avoid eyes and mouth. Dosage for Adults and Children over 12 years: One spray into each nostril up to 3 times daily, as needed. Do not exceed 3 applications daily into each nostril. The last dose can be applied before going to bed. For full instructions see enclosed leaflet.

  • Ingredients

    Active ingredient: Xylometazoline Hydrochloride 0.1% w/v, (1 mg/ml), Each application contains: 140 Micrograms of Xylometazoline Hydrochloride, Also contains: Benzalkonium Chloride, Disodium Phosphate Dodecahydrate, Disodium Edetate, Sodium Dihydrogen Phosphate Dihydrate Sodium Chloride, Sorbitol Non Crystallising Liquid (E420), Hypromellose and Purified Water, See leaflet for further information